Literature DB >> 17040932

Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample.

L Shahab1, M J Jarvis, J Britton, R West.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is the fourth most common cause of death worldwide. It is caused primarily by cigarette smoking. Given its importance, it is remarkable that reliable national prevalence data are lacking for most countries. This study provides estimates of the national prevalence of COPD in England, the extent of under-detection of the disorder, and patterns of cigarette smoking, dependence, and motivation to stop smoking in those with the disease.
METHODS: Data from 8215 adults over the age of 35 who participated in the Health Survey for England were analysed. Information was obtained on self-reported and cotinine validated smoking status, cigarette dependence, motivation to stop smoking, COPD defined by spirometry using joint American Thoracic Society and European Respiratory Society criteria, and self-reports of diagnosis with respiratory disorders.
RESULTS: Spirometry-defined COPD was present in 13.3% (95% CI 12.6 to 14.0) of participants, over 80% of whom reported no respiratory diagnosis. Even among people with severe or very severe COPD by spirometric assessment, only 46.8% (95% CI 39.1 to 54.6) reported any diagnosed respiratory disease. A total of 34.9% (95% CI 32.1 to 37.8) of people with spirometry-defined COPD were smokers compared with 22.4% (95% CI 21.4 to 23.4) of those without, and smoking prevalence increased with disease severity. Smokers with spirometry-defined COPD were more cigarette dependent but had no greater desire to quit than other smokers.
CONCLUSION: COPD is common among adults in England and is predominantly undiagnosed. In smokers it is associated with higher degrees of cigarette dependence but not with a greater motivation to stop smoking.

Entities:  

Mesh:

Year:  2006        PMID: 17040932      PMCID: PMC2117062          DOI: 10.1136/thx.2006.064410

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  34 in total

Review 1.  The challenge of providing better care for patients with chronic obstructive pulmonary disease: the poor relation of airways obstruction?

Authors:  P Calverley; D Bellamy
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

2.  Interpreting COPD prevalence estimates: what is the true burden of disease?

Authors:  R J Halbert; Sharon Isonaka; Dorothy George; Ahmar Iqbal
Journal:  Chest       Date:  2003-05       Impact factor: 9.410

3.  Prevalence of hardcore smoking in England, and associated attitudes and beliefs: cross sectional study.

Authors:  Martin J Jarvis; Jane Wardle; Jo Waller; Lesley Owen
Journal:  BMJ       Date:  2003-05-17

4.  Chronic bronchitis among French adults: high prevalence and underdiagnosis.

Authors:  G J Huchon; A Vergnenègre; F Neukirch; G Brami; N Roche; P M Preux
Journal:  Eur Respir J       Date:  2002-10       Impact factor: 16.671

5.  Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies.

Authors:  B Lundbäck; A Lindberg; M Lindström; E Rönmark; A C Jonsson; E Jönsson; L G Larsson; S Andersson; T Sandström; K Larsson
Journal:  Respir Med       Date:  2003-02       Impact factor: 3.415

6.  Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease.

Authors:  O Kornmann; K M Beeh; J Beier; U P Geis; M Ksoll; R Buhl
Journal:  Respiration       Date:  2003 Jan-Feb       Impact factor: 3.580

7.  The burden of COPD in the U.K.: results from the Confronting COPD survey.

Authors:  M Britton
Journal:  Respir Med       Date:  2003-03       Impact factor: 3.415

8.  Bronchodilator reversibility testing in chronic obstructive pulmonary disease.

Authors:  P M A Calverley; P S Burge; S Spencer; J A Anderson; P W Jones
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

Review 9.  Smoking cessation for chronic obstructive pulmonary disease.

Authors:  R M van der Meer; E J Wagena; R W J G Ostelo; J E Jacobs; C P van Schayck
Journal:  Cochrane Database Syst Rev       Date:  2003

10.  The effect of smoking intervention and an inhaled bronchodilator on airways reactivity in COPD: the Lung Health Study.

Authors:  Robert A Wise; Richard E Kanner; Paula Lindgren; John E Connett; Murray D Altose; Paul L Enright; Donald P Tashkin
Journal:  Chest       Date:  2003-08       Impact factor: 9.410

View more
  88 in total

1.  EKG of the month.

Authors:  J R Tobin; R Nemickas; P J Scanlon; J F Moran; S Johnson; R M Gunnar
Journal:  IMJ Ill Med J       Date:  1975-12

2.  Underdiagnosed chronic obstructive pulmonary disease in England: new country, same story.

Authors:  D M Mannino
Journal:  Thorax       Date:  2006-12       Impact factor: 9.139

3.  Diagnosis of COPD.

Authors:  Emanuela Falaschetti; Maureen P Swanney; Robert O Crapo; John L Hankinson; Robert L Jensen; Ole F Pedersen; Philip H Quanjer; Gregg L Ruppel; Jan P Schouten
Journal:  Thorax       Date:  2007-10       Impact factor: 9.139

Review 4.  A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids.

Authors:  M A Giembycz; M Kaur; R Leigh; R Newton
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

5.  Passive smoking and chronic obstructive pulmonary disease mortality: findings from the Japan collaborative cohort study.

Authors:  Shigekazu Ukawa; Akiko Tamakoshi; Hiroshi Yatsuya; Kazumasa Yamagishi; Masahiko Ando; Hiroyasu Iso
Journal:  Int J Public Health       Date:  2017-02-17       Impact factor: 3.380

6.  Smoking cessation in chronic obstructive pulmonary disease: an effective medical intervention.

Authors:  Stefan Andreas; Thomas Hering; Stephan Mühlig; Dennis Nowak; Tobias Raupach; Heinrich Worth
Journal:  Dtsch Arztebl Int       Date:  2009-04-17       Impact factor: 5.594

7.  Asymptomatic COPD and NICE guidelines.

Authors:  Gary Parkes
Journal:  Br J Gen Pract       Date:  2011-04       Impact factor: 5.386

Review 8.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

Review 9.  Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness.

Authors:  Farzaneh Sanei; Tom Wilkinson
Journal:  Ther Adv Respir Dis       Date:  2016-05-18       Impact factor: 4.031

Review 10.  The pathophysiology of bronchiectasis.

Authors:  Paul T King
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.